Quarterly report pursuant to Section 13 or 15(d)

4. STOCKHOLDERS' EQUITY (Details 2)

v3.5.0.2
4. STOCKHOLDERS' EQUITY (Details 2) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Stock-based compensation expense        
Total stock-based compensation expense $ 262,963 $ 447,932 $ 996,088 $ 1,221,662
Research and development        
Stock-based compensation expense        
Total stock-based compensation expense 95,076 184,302 383,909 514,107
Plasma centers        
Stock-based compensation expense        
Total stock-based compensation expense 15,289 12,457 40,044 35,813
General and administrative        
Stock-based compensation expense        
Total stock-based compensation expense $ 152,598 $ 251,173 $ 572,135 $ 671,742